Wordt geladen...
In Reply
Many factors contribute to patient survival in metastatic breast cancer and other late-stage cancers. It is doubtful that adjuvant therapy causes a worse survival outcome. This being said, should resistance develop following adjuvant therapy, the patient needs to be offered a first-line solution tha...
Bewaard in:
| Gepubliceerd in: | Oncologist |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
AlphaMed Press
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4294611/ https://ncbi.nlm.nih.gov/pubmed/25589501 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0284 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|